Health & Veritas

Howie and Harlan are joined by Yale School of Medicine sleep specialist Christine Won to discuss what makes for a good night's sleep and why sleep trackers and supplements may do more harm than good. Amid renewed discussion of "Medicare for All," Howie explains why Medicare falls short of universal coverage for current beneficiaries and proposes reforms; Harlan examines common misconceptions about...

Howie and Harlan are joined by Yale School of Public Health senior fellow Ashwin Vasan to discuss the ambitious agenda he pursued as New York City health commissioner: helping New Yorkers live longer, transforming mental healthcare, and rethinking what government can do to make people healthier. Howie examines the blood clots suffered by Philadelphia Eagles quarterback Jalen Hurts and the question...

Howie and Harlan discuss new research into the biological mechanisms behind long COVID and other post-infectious syndromes, how the FDA can ensure the safety of AI-powered medical tools, and why prior authorization can discourage necessary care even when treatments are ultimately approved. They also examine an early flu season, the changing calculus of COVID vaccination, and the continuing surge i...

Howie and Harlan are joined by Yale School of Medicine cardiologist Eric Velazquez to discuss how advances in treatment have transformed cardiovascular medicine and how technology could make care more accessible and equitable. Howie reports on a possible case of plague in Russia; Harlan reflects on how AI is changing the relationship between doctors and patients—and what that means for medical edu...

Howie and Harlan are joined by journalist Gary Wolf, author of the new book The Quantified Self: Learning to Observe , and patient researcher Sara Riggare, who has spent years studying her own experience with Parkinson's disease to better understand and manage her health. They discuss how systematic self-observation can help people ask better questions and learn more about their own health. Howie...

Howie and Harlan are joined by pediatric cardiologist Emily Bucholz to discuss her work treating fetal heart abnormalities across a multistate region and the challenges of bringing specialized pediatric care to patients far from major medical centers. For Suicide Prevention Month, Howie examines evidence that restricting access to lethal means can prevent suicide; Harlan pays tribute to the late Y...

Howie and Harlan are joined by Omar Lateef, CEO of Chicago's Rush University System for Health, to discuss balancing the financial pressures facing hospitals with commitments to patient care, community health, and research—and why healthcare leaders will need to rethink traditional models of care. Howie examines how proposed changes to student and exchange visitor visas could affect international...

Howie and Harlan are joined by cardiologist Aakriti Gupta to discuss advances in minimally invasive heart valve treatment, her work to expand access to cardiovascular care through technology and AI, and a major clinical trial on aortic valve replacement. Howie examines claims that immigration is driving the surge in measles cases; Harlan discusses disappointing trial results for two drugs aimed at...

Howie and Harlan discuss health headlines including the ongoing cyclosporiasis outbreak; a recent FDA decision allowing pharmacies to compound certain peptides; and a concerning report from Medicare trustees on the program's financial future. They also dive into the health habits they're changing this year and a new feature from ChatGPT allowing users to connect medical records and health data to...

Howie and Harlan are joined by Melanie Matheu, co-founder and chief scientific officer of Lyric Bio, who also shares evidence-based health and science information on TikTok as LaughterinLight PhD. They discuss developing new antibody therapies, building biotech companies, and communicating complex science to the public. Harlan warns that AI could drive up healthcare costs unless payment models cha...

Howie and Harlan are joined by Shivan Mehta, associate chief innovation officer at the University of Pennsylvania Health System, to discuss how healthcare organizations can use behavioral science to remove barriers that keep patients from getting recommended care. Harlan warns that ill-defined rules governing scientific collaboration with China could chill medical research; Howie revisits the disc...

Howie and Harlan are joined by Kate Heilpern, president of Yale New Haven Hospital, to discuss the hospital's 200-year history, the financial pressures facing health systems, and how Yale New Haven is balancing innovation with its mission to serve the local community. Harlan examines the growing burden of U.S. healthcare costs; Howie highlights encouraging trends in infant mortality, life expectan...

In this special episode, Howie and Harlan revisit their conversation with trauma surgeon Selwyn Rogers, whose book Healing the Gun Violence Epidemic: Ending Violence, Rebuilding Communities, and a Trauma Surgeon's Vision for Restoring Hope was published on July 7. Show notes: Selwyn Rogers: Healing the Gun Violence Epidemic: Ending Violence, Rebuilding Communities, and a Trauma Surgeon's Vision fo...

Howie and Harlan are joined by Jessica Federer, managing director of the Women's Health Fund and a member of the Yale Institutional Review Board, to discuss how investors can help address the dearth of research on medical problems facing women and why she's optimistic about the future of women's health. Harlan explains how caps on indirect costs affect institutional staffing and research agendas;...

Howie and Harlan are joined by Yale School of Public Health biostatistician Bhramar Mukherjee to discuss how statisticians help researchers turn observations into evidence. Harlan examines a new study linking updated COVID vaccination to lower cardiovascular risk and explains why a headline-grabbing result may not settle the question; Howie discusses new Medicaid work requirements and the danger t...

Howie and Harlan are joined by Ingrid Katz, director of the Yale Institute for Global Health, to discuss why HIV continues to spread despite the existence of cheap and effective treatment, what AIDS activism can teach us about tackling chronic diseases like hypertension, and what outbreaks like Ebola reveal about the consequences of fragile health systems. Harlan reports on a breach of UK Biobank...

Howie and Harlan discuss healthcare headlines including proposed changes to federal research funding, an outbreak of New World screwworm in Texas cattle, and the debate over free expression after researchers were removed from the American Diabetes Association meeting for distributing an editorial critical of federal science policies. They also examine the future of generic GLP-1 drugs, a new Medic...

Howie and Harlan are joined by Mark Siegel, director of Yale's internal medicine residency program, to discuss his approach to mentoring young physicians and building a medical community grounded in purpose and compassion. Harlan examines a breakthrough targeted therapy that could reshape the treatment of pancreatic cancer and other hard-to-treat cancers; Howie tracks the Ebola outbreak in the Dem...

Howie is joined by guest host Megan Ranney, dean of the the Yale School of Public Health, for a live episode recorded at the Yale Innovation Summit, featuring conversations with five innovators at the intersection of healthcare, public health, and entrepreneurship. Jaya Dadwal , a recent graduate of the School of Public Health and founder of forEVA Health, focused on raising healthcare standards f...

Howie and Harlan are joined by Nicholas Christakis, director of Yale's Human Nature Lab, to discuss his research on social networks, human connection, and the forces that help societies cooperate and endure. Harlan discusses promising phase 3 results for retatrutide, Eli Lilly's experimental "triple G" obesity drug; Howie provides an update on the fast-growing Ebola outbreak in the Democratic Repu...

Howie and Harlan discuss how AI is transforming medical research and publishing, the growing role of consumer health platforms and wearables, new advances in stroke treatment, and the debate over rising hospital costs. They also examine the FDA's approval of flavored vaping products and the nomination of a new surgeon general. Watch a video version of this episode on YouTube. Show notes: Social Me...

Howie and Harlan are joined by Josh Geballe, head of Yale Ventures, to discuss how changes in Yale's mindset, policies, and support systems have helped turn university research into impactful companies. Harlan examines the growing problem of AI-hallucinated citations in published research; Howie provides an update on the deadly Andes hantavirus outbreak aboard a cruise ship. Show notes: Fake Citat...

Howie and Harlan are joined by Lee Schwamm, the Yale School of Medicine's associate dean for digital strategy & transformation and chief digital health officer of the Yale New Haven Health System, to discuss how the system is working to rapidly evaluate and deploy AI tools without compromising patient safety and oversight. Harlan highlights vaccine studies reportedly held back from publication and...

Howie and Harlan are joined by Yale School of Medicine liver specialist Wolfram Goessling, who reflects on his experience surviving a rare cancer and how it reshaped his approach to patient care, communication, and leadership. Harlan discusses a Utah pilot program that is letting AI authorize prescription renewals, prompting alarm from physicians; Howie reports on a study challenging the effective...

Howie and Harlan take on tough questions at the intersection of medicine and society. They trace the deadly history of anti-vaccine activism, unpack Yale's report on trust in higher education, and explore the peptide craze. They also confront the rising moral distress among clinicians working in systems that too often prevent them from caring for patients the way they were trained to. Plus, studen...